Real-world use of nirmatrelvir-ritonavir: who benefits?

被引：1
|
作者：
Molina, Kyle C. [1 ,2 ]
Ginde, Adit A. [1 ]
机构：
[1] Colorado Univ, Dept Emergency Med, Sch Med, Aurora, CO 80045 USA
[2] Scripps Hlth, La Jolla, CA 92037 USA
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 07期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/S1473-3099(23)00180-9
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：765 / 767
页数：3
相关论文
共 50 条
  • [41] Real-World Evidence of the Top 100 Prescribed Drugs in the USA and Their Potential for Drug Interactions with Nirmatrelvir; Ritonavir
    Jacqueline Gerhart
    Florin Draica
    Michael Benigno
    Jo Atkinson
    Maya Reimbaeva
    Domenick Francis
    Nathalie Baillon-Plot
    Gurinder Singh Sidhu
    Bharat D. Damle
    The AAPS Journal, 25
  • [42] Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study
    Evans, Andrew
    Qi, Cathy
    Adebayo, Jubril Omololu
    Underwood, Jonathan
    Coulson, James
    Bailey, Rowena
    Lyons, Ronan
    Edwards, Adrian
    Cooper, Alison
    John, Gareth
    Akbari, Ashley
    JOURNAL OF INFECTION, 2023, 86 (04) : 352 - 360
  • [43] Characterization of nirmatrelvir-ritonavir (Paxlovid®) calls managed by a regional poison center
    Lam, Angela
    Yemets, Masha
    Couch, Denise
    Leonard, James
    CLINICAL TOXICOLOGY, 2023, 61 : 109 - 109
  • [44] Drug Interactions With Nirmatrelvir-Ritonavir in Older Adults Using Multiple Medications
    Ross, Sydney B.
    Bortolussi-Courval, Emilie
    Hanula, Ryan
    Lee, Todd Campbell
    Goodwin Wilson, Marnie
    McDonald, Emily G.
    JAMA NETWORK OPEN, 2022, 5 (07) : E2220184
  • [45] Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs
    Saravolatz, Louis D.
    Depcinski, Shawn
    Sharma, Mamta
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (01) : 165 - 171
  • [46] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19
    Cheng, Franco Wing Tak
    Yan, Vincent Ka Chun
    Wan, Eric Yuk Fai
    Chui, Celine Sze Ling
    Lai, Francisco Tsz Tsun
    Wong, Carlos King Ho
    Li, Xue
    Zhang, Irene Ran
    Tang, Sydney Chi Wai
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (05): : 1244 - 1253
  • [47] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19
    Focosi, Daniele
    Nicastri, Emanuele
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (10)
  • [48] Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting
    Kwok, Wang Chun
    Tsoi, Man Fung
    Leung, Sze Him Isaac
    Tsui, Chung Ki
    Tam, Terence Chi Chun
    Ho, James Chung Man
    Lam, David Chi Leung
    Ip, Mary Sau Man
    Ho, Pak Leung
    VIRUSES-BASEL, 2023, 15 (03):
  • [49] Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical Settings
    Zatovkanukova, Petra
    Vesely, Dalibor
    Sliva, Jiri
    PATHOGENS, 2024, 13 (12):
  • [50] Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence
    Karniadakis, Ioannis
    Mazonakis, Nikolaos
    Tsioutis, Constantinos
    Papadakis, Michail
    Markaki, Ioulia
    Spernovasilis, Nikolaos
    INFECTIOUS DISEASE REPORTS, 2023, 15 (06) : 662 - 678
12345